Skip to main content

PREDICT Archives

BioVU celebrates 15 years supporting personalized medicine

Jun. 8, 2022—BioVU is celebrating its 15th year and has enabled hundreds of studies and publications exploring the genetic underpinnings of a host of conditions including cancer, heart disease and diabetes. 

Read more


Roden honored with Oscar B. Hunter Career Award in Therapeutics

Mar. 15, 2021—Dan Roden, MD, Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center, received the Oscar B. Hunter Career Award in Therapeutics last week at the virtual annual meeting of the American Society for Clinical Pharmacology and Therapeutics.

Read more


PREDICT program expands, opens new Genomics Clinic

Apr. 30, 2020—A new clinic opening at Vanderbilt University Medical Center will help doctors and patients choose the best drugs for their medical conditions based on the patients’ unique genetic makeup.

Read more


Personalized drug prescribing program expands, upgrades

Jan. 25, 2018—Vanderbilt University Medical Center (VUMC) has expanded and relaunched genetic testing to predict patient responses to drugs.

Read more


Study looks at doctors’ response to genetic testing

Mar. 31, 2016—A new clinical implementation study from Vanderbilt University Medical Center measures how physicians have responded to the introduction of routine genetic testing to predict patient response to the commonly prescribed antiplatelet drug clopidogrel.

Read more


Roden named to NIH’s genomics advisory council

Jun. 12, 2014—Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH).

Read more


PREDICT program lands informatics innovation award

Feb. 6, 2014—Healthcare Informatics Magazine has awarded Vanderbilt University Medical Center third place in its 2014 Innovator Awards.

Read more


Pharmacogenomic testing costs studied

Oct. 17, 2013—A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions.

Read more


Transplant drug added to PREDICT program

Aug. 15, 2013—Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.

Read more


VUMC’s Denny lands award from informatics group

Nov. 8, 2012—Joshua Denny, M.D., M.S., assistant professor of Biomedical Informatics and Medicine and a key contributor to Vanderbilt University’s personalized medicine initiative, is the 2012 recipient of the New Investigator Award from the American Medical Informatics Association (AMIA).

Read more


Patients’ genetic data helps hone warfarin dosing

Nov. 1, 2012—Warfarin dosing at Vanderbilt University Medical Center just got safer and more effective.

Read more


PREDICT helps pinpoint right statin for patient

Oct. 4, 2012—When O.T. Hayes, 67, of Lebanon, Tenn., first starting seeing his cardiologist, David Hansen, M.D., for treatment of his coronary artery disease, it was hard to predict which of the various medications available would help control Haynes’ high cholesterol.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more